Starling Oncology Warrant
STLNW
16 hedge funds and large institutions have $807K invested in Starling Oncology Warrant in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
98% more capital invested
Capital invested by funds: $407K → $807K (+$400K)
14% more funds holding
Funds holding: 14 → 16 (+2)
0.13% more ownership
Funds ownership: 5.96% → 6.09% (+0.13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$14K |
| 2 |
Walleye Capital
New York
|
+$9.51K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$4.98K |
| 4 |
Two Sigma Investments
New York
|
+$4.74K |
| 5 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$4.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$8.73K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.86K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.68K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$88 |
STLNW Hedge Fund Activity: Q4 2023 in Review
16 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Warrant (STLNW) for Q4 2023, worth a combined $807K — up 98% from $407K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new STLNW positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Man Group, opening a new position worth an estimated $14K. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $8.73K sold.
- 16 institutional investors held Starling Oncology Warrant (STLNW) as of Q4 2023, up from 14 in Q3 2023.
- Funds reported $807K of Starling Oncology Warrant stock for Q4 2023, up 98% quarter-over-quarter.
- 4 funds opened new Starling Oncology Warrant positions in Q4 2023 and 2 closed out, a net change of +2 holders.
- The largest Starling Oncology Warrant buyer in Q4 2023 was Man Group, an estimated $14K added.
- The largest Starling Oncology Warrant seller in Q4 2023 was Jefferies Financial Group, an estimated $8.73K sold.
Based on aggregated 13F filings for Q4 2023.